- Home
- PHAT vs AIV Comparison
PHAT vs AIV Comparison
Compare PHAT & AIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- AIV
- Stock Information
- Founded
- PHAT 2018
- AIV 1975
- Country
- PHAT United States
- AIV United States
- Employees
- PHAT N/A
- AIV N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- AIV Real Estate Investment Trusts
- Sector
- PHAT Health Care
- AIV Real Estate
- Exchange
- PHAT Nasdaq
- AIV Nasdaq
- Market Cap
- PHAT 1.2B
- AIV 1.2B
- IPO Year
- PHAT 2019
- AIV 1994
- Fundamental
- Price
- PHAT $8.78
- AIV $8.62
- Analyst Decision
- PHAT Strong Buy
- AIV
- Analyst Count
- PHAT 4
- AIV 0
- Target Price
- PHAT $22.50
- AIV N/A
- AVG Volume (30 Days)
- PHAT 1.9M
- AIV 974.5K
- Earning Date
- PHAT 11-07-2024
- AIV 11-07-2024
- Dividend Yield
- PHAT N/A
- AIV N/A
- EPS Growth
- PHAT N/A
- AIV N/A
- EPS
- PHAT N/A
- AIV N/A
- Revenue
- PHAT $26,270,000.00
- AIV $204,735,000.00
- Revenue This Year
- PHAT $6,714.96
- AIV N/A
- Revenue Next Year
- PHAT $293.69
- AIV $6.56
- P/E Ratio
- PHAT N/A
- AIV N/A
- Revenue Growth
- PHAT N/A
- AIV 13.91
- 52 Week Low
- PHAT $6.07
- AIV $6.49
- 52 Week High
- PHAT $19.71
- AIV $9.49
- Technical
- Relative Strength Index (RSI)
- PHAT 23.73
- AIV 49.25
- Support Level
- PHAT $8.91
- AIV $8.40
- Resistance Level
- PHAT $19.05
- AIV $8.81
- Average True Range (ATR)
- PHAT 1.74
- AIV 0.23
- MACD
- PHAT -1.05
- AIV 0.02
- Stochastic Oscillator
- PHAT 2.19
- AIV 67.50
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About AIV Apartment Investment and Management Company
Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. The company generates majority of revenue from operating segment.